Key clinical point: Previously available antivirals and new therapeutics show promise in treating human coronaviruses.
Major finding: Small-molecule, antihuman CoV therapies targeting different stages of the CoV life cycle are being developed.
Study details: A review of current research into anticoronavirus therapeutics.
Disclosures: The authors reported that they had no financial conflicts of interest.
Pillaiyar T et al. Drug Discov Today. 2020 Jan 30. doi: 10.1016/j.drudis.2020.01.015.